North America continues to dominate the Human Biobanking Equipment Market owing to the strong presence of advanced healthcare infrastructure, extensive genomic research programs, and increasing investments in biobanking facilities. The region benefits from widespread adoption of automated storage systems, cryogenic equipment, and sample management technologies. Growing collaborations between research institutions, pharmaceutical companies, and government agencies are further strengthening market expansion across North America.

According to The Insight Partners, the Human Biobanking Equipment Market is expected to grow from US$ 1.46 billion in 2025 to US$ 1.85 billion by 2034, registering a CAGR of 2.65% during 2026–2034. The market is witnessing steady growth due to the increasing importance of biological sample preservation in medical research, drug development, regenerative medicine, and personalized healthcare. Biobanking equipment plays a critical role in maintaining the integrity, quality, and viability of biological specimens, including blood, tissues, DNA, RNA, stem cells, and other biospecimens.

The growing prevalence of chronic…

North America holds a significant share of the 3D hip and knee implant market, supported by advanced healthcare infrastructure, increasing adoption of additive manufacturing technologies, and a rising prevalence of orthopedic disorders. The region continues to witness strong demand for personalized implant solutions, particularly among the aging population. Growing investments in medical innovation and favorable reimbursement frameworks further contribute to market expansion across North America.

According to The Insight Partners, the 3D Hip and Knee Implant Market size is expected to reach US$ 24.96 billion by 2034 from US$ 6.96 billion in 2025. The market is estimated to record a robust CAGR of 17.31% from 2026 to 2034. The remarkable growth trajectory reflects the increasing integration of 3D printing technologies in orthopedic implant manufacturing, enabling customized solutions that improve patient outcomes and surgical precision.  

The healthcare industry has witnessed significant transformation with the adoption of additive manufacturing techniques. In orthopedic applications, 3D…

North America continues to hold a significant share of the Infant Incubator Market due to its advanced neonatal healthcare infrastructure, increasing investments in neonatal intensive care units (NICUs), and widespread adoption of technologically advanced infant care equipment. The region also benefits from favorable reimbursement policies and growing awareness regarding neonatal health and premature birth management.

Infant Incubator Market Overview

According to The Insight Partners, the Infant Incubator Market size is expected to reach US$ 4.29 Billion by 2034 from US$ 2.31 Billion in 2025. The market is estimated to record a CAGR of 7.13% from 2026 to 2034.

Infant incubators are specialized medical devices designed to provide a controlled environment for newborn babies, particularly premature infants and those with critical health conditions. These devices help maintain optimal temperature, humidity, and oxygen levels while protecting infants from infections and environmental stressors. As neonatal healthcare continues to advance globally, the demand for sophisticated infant incubators is…

The remotely medical treatment device market in North America continues to dominate the global landscape due to advanced healthcare infrastructure, widespread adoption of telemedicine technologies, and increasing investments in digital health solutions. The region benefits from strong government support, favorable reimbursement policies, and growing demand for remote patient monitoring systems among aging populations and patients with chronic diseases.

According to The Insight Partners, the Remotely Medical Treatment Device Market is expected to grow significantly over the forecast period. The market size is projected to reach US$ 33.88 billion by 2034, up from US$ 16.12 billion in 2025, registering a robust CAGR of 8.60% from 2026 to 2034. The increasing integration of digital technologies in healthcare, rising demand for remote patient care, and expanding telehealth services are among the primary factors driving market expansion worldwide.

Remotely medical treatment devices have emerged as essential tools in modern healthcare systems. These devices enable healthcare providers…

North America holds a significant share of the global Platelet Agitator Market, supported by its advanced healthcare infrastructure, strong blood banking network, and increasing demand for platelet transfusions. The region benefits from the growing prevalence of hematological disorders, rising surgical procedures, and continuous investments in transfusion medicine technologies. Healthcare institutions across North America are increasingly adopting advanced platelet storage systems to maintain platelet viability and safety.

According to The Insight Partners, the Platelet Agitator Market size is expected to reach US$ 302.4 million by 2034 from US$ 194.09 million in 2025. The market is estimated to record a CAGR of 5.05% from 2026 to 2034. The increasing demand for blood components, growing awareness regarding safe platelet storage, and expanding healthcare infrastructure across developing economies are among the key factors driving market growth.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00007661

Platelet agitators are specialized medical devices used to continuously agitate platelet concentrates during storage. These systems play a crucial…

North America continues to dominate the Hemoglobin A1c Testing Devices Market due to the high prevalence of diabetes, advanced healthcare infrastructure, and widespread adoption of diagnostic technologies. The region benefits from strong reimbursement frameworks, increasing awareness regarding diabetes management, and continuous investments in point-of-care testing solutions. Growing demand for early diagnosis and routine monitoring of blood glucose levels is further supporting market expansion across North America.

Market Overview

According to The Insight Partners, the Hemoglobin A1c Testing Devices Market is expected to reach US$ 3.7 billion by 2031 and is anticipated to register a CAGR of 7.0% during 2025–2031. The market is experiencing substantial growth owing to the increasing global burden of diabetes, rising awareness regarding disease management, and growing demand for accurate and rapid diagnostic solutions.

Hemoglobin A1c (HbA1c) testing plays a crucial role in monitoring long-term blood glucose levels and assessing diabetes management effectiveness. Unlike conventional glucose tests that provide short-term readings,…

North America continues to dominate the Surgical Site Infection Control Market due to the presence of advanced healthcare infrastructure, growing awareness regarding hospital-acquired infections, and stringent infection prevention regulations. The region benefits from significant investments in healthcare technologies, increasing surgical procedures, and widespread adoption of sterilization and disinfection solutions. Favorable reimbursement policies and strong focus on patient safety further contribute to market growth across North America.

Market Overview

According to The Insight Partners, the Surgical Site Infection Control Market size is expected to reach US$ 6.97 Billion by 2031. The market is anticipated to register a CAGR of 5.3% during 2025–2031. The increasing prevalence of healthcare-associated infections (HAIs), rising number of surgical procedures worldwide, and growing awareness regarding infection prevention measures are among the major factors driving market growth.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00004757

Surgical site infections (SSIs) remain one of the most common complications associated with surgical procedures, leading to prolonged hospital stays, increased healthcare…